In January, the Financial Industry Regulatory Authority released Regulatory Notice 12-03 regarding heightened supervision of “complex products.” 

The notice didn’t try to define what complex products are. Rather, it said the term includes “any product with multiple features that affect its investment returns differently under various scenarios.” Products fitting that description include structured notes, inverse or leveraged exchange-traded funds and asset-backed securities.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.